Skip to main content
Caplight Logo









AceAge Inc.

AceAge Inc.

Private
BurlingtonHealthcare & Life Scienceshttps://kariehealth.com

Last Round

Grant

Apr 14, 2022

Total Funding Raised

$5.7M

Company Overview

AceAge Inc. operates in Healthcare & Life Sciences and is based in Burlington. Its latest recorded funding round was a Grant round in April 2022.

AceAge Inc. is a healthcare technology company that develops and manufactures Karie, an automated medication dispensing system designed to improve medication adherence for seniors and patients with chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Health IoT, Telemedicine

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AceAge Inc. Comparables

Compare AceAge Inc. with similar companies based on industry and business-model similarity.

AceAge Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmRight Corporation
90%
Dose Health
87%
Hero Health
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AceAge Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 14, 2022
DebtMar 31, 2021
Series ADec 3, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

AceAge Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 198% MoM, from 44 to 131.

  • Jun 2, 2025

    Grew 18% QoQ, from 22 to 26 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

AceAge Inc. Filings

Explore SEC and related filing metadata, where available.

AceAge Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AceAge Inc.'s valuation, stock price, and market status.

Is AceAge Inc. a public or private company?

AceAge Inc. is a private company.

What is the current stock price of AceAge Inc.?

AceAge Inc. is a private company, so its shares have no public market price. Caplight tracks AceAge Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AceAge Inc. worth (valuation)?

Valuation information for AceAge Inc. is not publicly available.

Can I buy AceAge Inc. stock?

AceAge Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AceAge Inc.'s last funding round?

AceAge Inc.'s most recent funding round was Grant on April 14, 2022.

Who are the main investors in AceAge Inc.?

Key investors in AceAge Inc. include Longliv Ventures.

Will AceAge Inc. IPO soon?

No public IPO plans have been announced for AceAge Inc..

How can I track AceAge Inc. secondary market activity?

Caplight tracks bids, offers, and trades in AceAge Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersBurlington
Employee Range12
Year Founded2016
Last FundingApr 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?